Abstract
BackgroundPreoperative differentiation between benign and malignant masses can be challenging. The aim of this research was to evaluate the performance of a modified multivariate index assay (MIA) in detecting ovarian cancer and to compare the effectiveness of gynecologist assessment, cancer antigen (CA) 125, and MIA for identifying ovarian masses with high suspicion of malignancy.ResultsThis prospective observational study included 150 women with ovarian masses who underwent surgery in the Maternity Teaching Hospital from December 2014 to May 2016. Preoperative estimation of modified MIA, assessment by a gynecologist, and CA 125 level correlated with the surgical histopathology. A modified MIA was implemented because of lack of access to the software typically used. Among 150 enrolled women there were 30 cases of malignancy, including 8 cases (26%) of early-stage ovarian cancer and 22 cases (74%) of late-stage cancer. MIA showed high specificity (96.7%) in detecting cancer and a sensitivity of 70%, with a positive predictive value of 84% and a negative predictive value of 92.8%. No significant differences were detected between the MIA results and the histopathology results (P = 0.267). For early-stage ovarian cancer, the sensitivity of MIA was 100% compared with 75% for CA 125 alone.ConclusionMIA seems to be effective for evaluation of ovarian tumors with higher specificity and positive predictive value than CA 125 while maintaining high negative predictive value and with only a slightly lower overall sensitivity. For evaluation of early-stage ovarian cancer, MIA showed a much higher sensitivity that markedly outperformed CA 125 alone. This modified MIA strategy may be particularly useful in low resource setting.
Highlights
Preoperative differentiation between benign and malignant masses can be challenging
10% of women will have some form of surgery for an ovarian mass during their lifetime, and 20% of borderline ovarian tumors appear as simple cysts on ultrasound many of these tumors may proceed to malignancy later on [2]
One-fourth of the cases (25.3%) were suspected to be malignant according to the opinion of the senior gynecologists prior to the operation, whereas 20% were proven to be malignant by histopathological examination (Table 5)
Summary
Preoperative differentiation between benign and malignant masses can be challenging. Estimation of the risk of malignancy is essential when assessing ovarian masses, and the risk for malignancy has been assessed using 80 different models, including the Royal College of Obstetrician and Gynecologists guidelines. The American College of Obstetricians and Gynecologists and the Society of Obstetricians and Gynecologists of Canada have defined guidelines for the management of premenopausal women with a pelvic mass. These guidelines consider the following features suspicious for ovarian malignancy and warranting referral to a gynecological oncologist: serum CA 125 > 200 units/ml, ascites, evidence of abdominal
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.